EZH2 mutations and impact on clinical outcome: an analysis in 1,604 patients with newly diagnosed acute myeloid leukemia

The enhancer of zeste homolog 2 (EZH2) is a histone methyltransferase and functional core subunit of the polycomb repressive complex 2 (PRC2), which is a key epigenetic regulator involved in embryonic development and transcriptional repression of genes by catalyzing the methylation of histone H3 at

Saved in:
Bibliographic Details
Main Authors: Stasik, Sebastian (Author) , Krämer, Alwin (Author) , Müller-Tidow, Carsten (Author)
Format: Article (Journal) Editorial
Language:English
Published: 2020
In: Haematologica
Year: 2020, Volume: 105, Issue: 5, Pages: e228-e231
ISSN:1592-8721
DOI:10.3324/haematol.2019.222323
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3324/haematol.2019.222323
Verlag, lizenzpflichtig, Volltext: http://www.haematologica.org/content/105/5/e228
Get full text
Author Notes:Sebastian Stasik, Jan M. Middeke, Michael Kramer, Christoph Röllig, Alwin Krämer, Sebastian Scholl, Andreas Hochhaus, Martina Crysandt, Tim H. Brümmendorf, Ralph Naumann, Björn Steffen, Volker Kunzmann, Hermann Einsele, Markus Schaich, Andreas Burchert, Andreas Neubauer, Kerstin Schäfer-Eckart, Christoph Schliemann, Stefan Krause, Regina Herbst, Mathias Hänel, Norbert Frickhofen, Richard Noppeney, Ulrich Kaiser, Claudia D. Baldus, Martin Kaufmann, Zdenek Rácil, Uwe Platzbecker, Wolfgang E. Berdel, Jiri Mayer, Hubert Serve, Carsten Müller-Tidow, Gerhard Ehninger, Martin Bornhäuser, Johannes Schetelig, Christian Thiede

MARC

LEADER 00000caa a2200000 c 4500
001 1701013037
003 DE-627
005 20220818124227.0
007 cr uuu---uuuuu
008 200618s2020 xx |||||o 00| ||eng c
024 7 |a 10.3324/haematol.2019.222323  |2 doi 
035 |a (DE-627)1701013037 
035 |a (DE-599)KXP1701013037 
035 |a (OCoLC)1341339595 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Stasik, Sebastian  |d 1984-  |e VerfasserIn  |0 (DE-588)1074896149  |0 (DE-627)832659827  |0 (DE-576)443102309  |4 aut 
245 1 0 |a EZH2 mutations and impact on clinical outcome  |b an analysis in 1,604 patients with newly diagnosed acute myeloid leukemia  |c Sebastian Stasik, Jan M. Middeke, Michael Kramer, Christoph Röllig, Alwin Krämer, Sebastian Scholl, Andreas Hochhaus, Martina Crysandt, Tim H. Brümmendorf, Ralph Naumann, Björn Steffen, Volker Kunzmann, Hermann Einsele, Markus Schaich, Andreas Burchert, Andreas Neubauer, Kerstin Schäfer-Eckart, Christoph Schliemann, Stefan Krause, Regina Herbst, Mathias Hänel, Norbert Frickhofen, Richard Noppeney, Ulrich Kaiser, Claudia D. Baldus, Martin Kaufmann, Zdenek Rácil, Uwe Platzbecker, Wolfgang E. Berdel, Jiri Mayer, Hubert Serve, Carsten Müller-Tidow, Gerhard Ehninger, Martin Bornhäuser, Johannes Schetelig, Christian Thiede 
264 1 |c 2020 
300 |a 4 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Im Text ist EZH2 schräg gestellt 
500 |a Gesehen am 18.06.2020 
520 |a The enhancer of zeste homolog 2 (EZH2) is a histone methyltransferase and functional core subunit of the polycomb repressive complex 2 (PRC2), which is a key epigenetic regulator involved in embryonic development and transcriptional repression of genes by catalyzing the methylation of histone H3 at 
700 1 |a Krämer, Alwin  |e VerfasserIn  |0 (DE-588)1067780025  |0 (DE-627)819183431  |0 (DE-576)426900820  |4 aut 
700 1 |a Müller-Tidow, Carsten  |d 1968-  |e VerfasserIn  |0 (DE-588)1015101798  |0 (DE-627)705330230  |0 (DE-576)351197893  |4 aut 
773 0 8 |i Enthalten in  |t Haematologica  |d Pavia : Ferrata Storti Foundation, 2014  |g 105(2020), 5, Seite e228-e231  |h Online-Ressource  |w (DE-627)814204899  |w (DE-600)2805244-4  |w (DE-576)424051125  |x 1592-8721  |7 nnas  |a EZH2 mutations and impact on clinical outcome an analysis in 1,604 patients with newly diagnosed acute myeloid leukemia 
773 1 8 |g volume:105  |g year:2020  |g number:5  |g pages:e228-e231  |g extent:4  |a EZH2 mutations and impact on clinical outcome an analysis in 1,604 patients with newly diagnosed acute myeloid leukemia 
856 4 0 |u https://doi.org/10.3324/haematol.2019.222323  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u http://www.haematologica.org/content/105/5/e228  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20200618 
993 |a Editorial 
994 |a 2020 
998 |g 1015101798  |a Müller-Tidow, Carsten  |m 1015101798:Müller-Tidow, Carsten  |d 910000  |d 910100  |e 910000PM1015101798  |e 910100PM1015101798  |k 0/910000/  |k 1/910000/910100/  |p 32 
998 |g 1067780025  |a Krämer, Alwin  |m 1067780025:Krämer, Alwin  |d 910000  |d 910100  |e 910000PK1067780025  |e 910100PK1067780025  |k 0/910000/  |k 1/910000/910100/  |p 5 
999 |a KXP-PPN1701013037  |e 3688244109 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Im Text ist EZH2 schräg gestellt","Gesehen am 18.06.2020"],"relHost":[{"recId":"814204899","disp":"EZH2 mutations and impact on clinical outcome an analysis in 1,604 patients with newly diagnosed acute myeloid leukemiaHaematologica","titleAlt":[{"title":"journal of the European Hematology Association"}],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"pubHistory":["99.2014 -"],"origin":[{"publisher":"Ferrata Storti Foundation","dateIssuedDisp":"2014-","dateIssuedKey":"2014","publisherPlace":"Pavia"}],"title":[{"title_sort":"Haematologica","subtitle":"journal of the European Hematology Association : journal of the Ferrata Storti Foundation","title":"Haematologica"}],"part":{"volume":"105","text":"105(2020), 5, Seite e228-e231","year":"2020","pages":"e228-e231","extent":"4","issue":"5"},"id":{"issn":["1592-8721"],"zdb":["2805244-4"],"eki":["814204899"]},"physDesc":[{"extent":"Online-Ressource"}],"note":["Gesehen am 27.05.2022"]}],"id":{"eki":["1701013037"],"doi":["10.3324/haematol.2019.222323"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"physDesc":[{"extent":"4 S."}],"title":[{"title":"EZH2 mutations and impact on clinical outcome","subtitle":"an analysis in 1,604 patients with newly diagnosed acute myeloid leukemia","title_sort":"EZH2 mutations and impact on clinical outcome"}],"language":["eng"],"origin":[{"dateIssuedDisp":"2020","dateIssuedKey":"2020"}],"name":{"displayForm":["Sebastian Stasik, Jan M. Middeke, Michael Kramer, Christoph Röllig, Alwin Krämer, Sebastian Scholl, Andreas Hochhaus, Martina Crysandt, Tim H. Brümmendorf, Ralph Naumann, Björn Steffen, Volker Kunzmann, Hermann Einsele, Markus Schaich, Andreas Burchert, Andreas Neubauer, Kerstin Schäfer-Eckart, Christoph Schliemann, Stefan Krause, Regina Herbst, Mathias Hänel, Norbert Frickhofen, Richard Noppeney, Ulrich Kaiser, Claudia D. Baldus, Martin Kaufmann, Zdenek Rácil, Uwe Platzbecker, Wolfgang E. Berdel, Jiri Mayer, Hubert Serve, Carsten Müller-Tidow, Gerhard Ehninger, Martin Bornhäuser, Johannes Schetelig, Christian Thiede"]},"recId":"1701013037","person":[{"family":"Stasik","given":"Sebastian","display":"Stasik, Sebastian","role":"aut"},{"role":"aut","family":"Krämer","given":"Alwin","display":"Krämer, Alwin"},{"family":"Müller-Tidow","display":"Müller-Tidow, Carsten","given":"Carsten","role":"aut"}]} 
SRT |a STASIKSEBAEZH2MUTATI2020